USV is planning to introduce nutraceuticals for enhanced diabetes care, says MD Prashant Tewari

USV recently introduced Insuquick, a biosimilar Insulin Aspart designed for individuals with diabetes in India.

Related Keywords

India ,Prashant Tewari ,Indian Council Of Medical Research ,Novo Nordisk ,Insulin Aspart ,Managing Director ,Business Today ,Indian Council ,Medical Research ,Usv Pvt Ltd ,Biogenomics ,Nsuquick Release ,Biosimilar Insulin Aspart ,Iabetes Care In India ,Ake In India Product ,Rapid Acting Insulin ,Anaging Director Usv Pvt ,Investment Strategy ,Ral Anti Diabetic Sector ,Njectable Insulin ,Ndia 039s Diabetic Population ,Iabetes Treatment Options ,Sv Growth Trajectory ,Pre Diabetic Patients ,Cardiac Issues ,Ealthcare Burdens ,Sv Portfolio Expansion ,R Ampd Investment ,Quality Manufacturing ,